First-line Chemo-Immunotherapy in SCLC: Outcomes of a Binational Real-World Study
Laura Moliner, MD,Núria Zellweger, MSc, Sabine Schmid, MD,Martina Bertschinger, MD,Christine Waibel, MD,Ferdinando Cerciello, MD, PhD,Patrizia Froesch, MD, Michael Mark, MD, Adrienne Bettini, MD, Pirmin Häuptle, MD, Veronika Blum, MD,Lisa Holer, MSc,Stefanie Hayoz, PhD,Martin Früh, MD, Samreen Ahmed, FRCP, MD, MBBS, MSc, Shradha Bhagani, MD, Nicola Steele, MD, Hannah-Leigh Gray, BSc, Stephen D. Robinson, MD, Michael Davidson, MD (Res), Samantha Cox, MD, MSc, MBBCh,Taha Khalid, MD,Tom R. Geldart, MD, Luke Nolan, FRCS, PhD, Deborah C. Scott, MBChB (MRCP),Lindsay Hennah, MD, Tom Newsom-Davis, MD, PhD, Emma Rathbone, MD, PhD,Catherine Handforth, MD,Arshi Denton, MD, Shairoz Merchant, PhD, Fiona Blackhall, MD, PhD,Laetitia A. Mauti, MD, Raffaele Califano, MD,Sacha I. Rothschild, MD, PhD JTO Clinical and Research Reports（2025）
关键词
SCLC,Real-world data,Immunotherapy,Special populations
AI 理解论文
溯源树
样例
